Eric Wittbrodt, based in Washington, DC, US, is currently a Renal Evidence Strategy Lead at AstraZeneca, bringing experience from previous roles at AstraZeneca, Daiichi Sankyo, Inc. and Takeda Pharmaceuticals. Eric Wittbrodt holds a 2009 - 2013 MPH in Public Health @ University of North Carolina at Chapel Hill. With a robust skill set that includes Clinical Research, Hypertension, Nephrology, Medical Education, Rheumatology and more, Eric Wittbrodt contributes valuable insights to the industry. Eric Wittbrodt has 2 emails and 2 mobile phone numbers on RocketReach.